Search for: All records

Creators/Authors contains: "Zitnik, Marinka"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. Free, publicly-accessible full text available December 1, 2027
  2. Protein representation learning has advanced rapidly with the scale-up of sequence and structure supervision, but most models still encode proteins either as per-residue token sequences or as single global embeddings. This overlooks a defining property of protein organization: proteins are built from recurrent, evolutionarily conserved substructures that concentrate biochemical activity and mediate core molecular functions. Although substructures such as domains and functional sites are systematically cataloged, they are rarely used as training signals or representation units in protein models. We introduce Magneton, an environment for developing substructure-aware protein models. Magneton provides (1) a dataset of 530,601 proteins annotated with over 1.7 million substructures spanning 13,075 types, (2) a training framework for incorporating substructures into existing protein models, and (3) a benchmark suite of 13 tasks probing representations at the residue, substructural, and protein levels. Using Magneton, we develop substructure-tuning, a supervised fine-tuning method that distills substructural knowledge into pretrained protein models. Across state-of-the-art sequence- and structure-based models, substructure-tuning improves function prediction, yields more consistent representations of substructure types never observed during tuning, and shows that substructural supervision provides information that is complementary to global structure inputs. 
    more » « less
    Free, publicly-accessible full text available May 22, 2027
  3. Protein structure is central to biological function, and enabling multimodal protein models requires joint reasoning over sequence, structure, and function. A key barrier is the lack of principled protein structure tokenizers (PSTs): existing approaches fix token size or rely on continuous vector codebooks, limiting interpretability, multi-scale control, and transfer across architectures. We introduce GeoBPE, a geometry-grounded PST that transforms continuous, noisy, multi-scale backbone conformations into discrete ``sentences'' of geometry while enforcing global constraints. Analogous to byte-pair encoding, GeoBPE generates a hierarchical vocabulary of geometric primitives by iteratively (i) clustering Geo-Pair occurrences with k-medoids to yield a resolution-controllable vocabulary; (ii) quantizing each Geo-Pair to its closest medoid prototype; and (iii) reducing drift through differentiable inverse kinematics that optimizes boundary glue angles under an SE(3) end-frame loss. GeoBPE offers compression (>10x reduction in bits-per-residue at similar distortion rate), data efficiency (>10x less training data), and generalization (maintains test/train distortion ratio of 1.0−1.1). It is architecture-agnostic: (a) its hierarchical vocabulary provides a strong inductive bias for coarsening residue-level embeddings from large PLMs into motif- and protein-level representations, consistently outperforming leading PSTs across 12 tasks and 24 test splits; (b) paired with a transformer, GeoBPE supports unconditional backbone generation via language modeling; and (c) tokens align with CATH functional families and support expert-interpretable case studies, offering functional meaning absent in prior PSTs. 
    more » « less
    Free, publicly-accessible full text available May 22, 2027
  4. Conditional generation models for longitudinal sequences can produce new or modified trajectories given a conditioning input. However, they often lack control over when the condition should take effect (timing) and which variables it should influence (scope). Most methods either operate only on univariate sequences or assume that the condition alters all variables and time steps. In scientific and clinical settings, interventions instead begin at a specific moment, such as the time of drug administration or surgery, and influence only a subset of measurements while the rest of the trajectory remains unchanged. CLEF learns temporal concepts that encode how and when a condition alters future sequence evolution. These concepts allow CLEF to apply targeted edits to the affected time steps and variables while preserving the rest of the sequence. We evaluate CLEF on 8 datasets spanning cellular reprogramming, patient health, and sales, comparing against 9 state-of-the-art baselines. CLEF improves immediate sequence editing accuracy by 16.28% (MAE) on average against their non-CLEF counterparts. Unlike prior models, CLEF enables one-step conditional generation at arbitrary future times, outperforming their non-CLEF counterparts in delayed sequence editing by 26.73% (MAE) on average. We test CLEF under counterfactual inference assumptions and show up to 62.84% (MAE) improvement on zero-shot conditional generation of counterfactual trajectories. In a case study of patients with type 1 diabetes mellitus, CLEF identifies clinical interventions that generate realistic counterfactual trajectories shifted toward healthier outcomes. 
    more » « less
    Free, publicly-accessible full text available May 22, 2027
  5. Protein language models (PLMs) are often assumed to capture evolutionary information by training on large protein sequence datasets. Yet it remains unclear whether PLMs can reason about evolution—that is, infer evolutionary relationships between sequences. We test this capability by evaluating whether standard PLM usage, frozen or fine-tuned embeddings with distance-based comparison, supports evolutionary reasoning. Existing PLMs consistently fail to recover phylogenetic structure, despite strong performance on sequence-level tasks such as masked-token and contact prediction. We present PHYLA, a hybrid state-space and transformer model that jointly processes multiple sequences and is trained using a tree-based objective across 3,000 phylogenies spanning diverse protein families. PHYLA outperforms the next-best PLM by 9% on tree reconstruction and 23% on taxonomic clustering while remaining alignment- and guide-tree-free. Although classical alignment pipelines achieve higher absolute accuracy, PHYLA narrows the gap and achieves markedly lower end-to-end runtime. Applied to real data, PHYLA reconstructs biologically accurate clades in the tree of life and resolves genome-scale relationships among Mycobacterium tuberculosis isolates. These findings suggest that, under standard usage, evolutionary reasoning does not reliably emerge from large-scale sequence modeling. Instead, PHYLA shows that models trained with phylogenetic supervision can reason about evolution more effectively, offering a biologically grounded path toward evolutionary foundation models. 
    more » « less
    Free, publicly-accessible full text available December 12, 2026
  6. Structure-based drug design (SBDD) leverages the three-dimensional geometry of proteins to identify potential drug candidates. Traditional approaches, rooted in physicochemical modeling and domain expertise, are often resource-intensive. Recent advancements in geometric deep learning, which effectively integrate and process 3D geometric data, alongside breakthroughs in accurate protein structure predictions from tools like AlphaFold, have significantly propelled the field forward. This article systematically reviews the state-of-the-art in geometric deep learning for SBDD. We begin by outlining foundational tasks in SBDD, discussing prevalent 3D protein representations, and highlighting representative predictive and generative models. Next, we provide an in-depth review of key tasks, including binding site prediction, binding pose generation, de novo molecule generation, linker design, protein pocket generation, and binding affinity prediction. For each task, we present formal problem definitions, key methods, datasets, evaluation metrics, and performance benchmarks. Lastly, we explore current challenges and future opportunities in SBDD. Challenges include oversimplified problem formulations, limited out-of-distribution generalization, biosecurity concerns related to the misuse of structural data, insufficient evaluation metrics and large-scale benchmarks, and the need for experimental validation and enhanced model interpretability. Opportunities lie in integrating biomedical AI agents, leveraging multimodal datasets, developing comprehensive benchmarks, establishing criteria aligned with clinical outcomes, and designing foundation models to expand the scope of design tasks. We also curatehttps://github.com/zaixizhang/Awesome-SBDD, reflecting ongoing contributions and new datasets in SBDD. 
    more » « less
    Free, publicly-accessible full text available April 30, 2027
  7. Free, publicly-accessible full text available March 20, 2027
  8. Free, publicly-accessible full text available February 1, 2027
  9. Free, publicly-accessible full text available September 9, 2026